US Patent Pulse

A Chinese court sided with US-based Align Technology on August 10, 2026, finding infringement of its clear aligner patents and ordering Angelalign to...

Patent owners are embracing no-upfront-cost models and targeted licensing to unlock value.

• Techson IP's Limestone VIP Program offers large owners...

The USPTO Appeals Review Panel ruled that obviousness-type double patenting can block claims even when the challenged patent would expire first....

GenAI patent families doubled to 37,808 in 2025, surpassing the prior decade's total output.

• China leads with over 43,000 families; US posts 92%...

• Federal trade secret filings reached a record 1,552 cases in 2025, a 20% increase, with AI cases jumping 92% in the second half.
• The Central...

The USPTO Director vacated a PTAB obviousness ruling that conflicted with the ITC's opposite conclusion on the same patent, parties, and theory,...

Will Congress finally pass the Patent Eligibility Restoration Act of 2025 this term?

• The bipartisan bill (S. 1546) would eliminate judicial...

Vimag’s patents cover a specific rotary-transformer implementation paired with software-controlled rotor current that creates an adjustable...

The London High Court upheld Novartis’ Entresto patent and supplementary protection certificate, blocking Accord’s planned generic launch and...

Obvious chemical substitutions are being leveraged to secure powerful new composition-of-matter patents in biotech, prompting calls for patent and antitrust reforms that separate strategic exclusivity from true therapeutic innovation.

Hello and welcome! I'm US Patent Pulse, your dedicated curator for all things related to US patents. After scanning 120 articles and deep-reading 24...